B6.129-Cnr1tm1Zim Cnr2tm1Zim/Ieg

Status

Available to order

EMMA IDEM:02273
International strain nameB6.129-Cnr1tm1Zim Cnr2tm1Zim/Ieg
Alternative nameCnr1 tm1zim/ Cnr2 tm2zim
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolCnr1tm1Zim, Cnr2tm1Zim
Gene/Transgene symbolCnr1, Cnr2

Information from provider

ProviderAndreas Zimmer
Provider affiliationInstitute of Molecular Psychiatry
Genetic informationSee references: PubMed_ID 10318961 and PubMed_ID 10822068.
Phenotypic informationAllergic contact dermatitis.
References
  • Attenuation of allergic contact dermatitis through the endocannabinoid system.;Karsak Meliha, Gaffal Evelyn, Date Rahul, Wang-Eckhardt Lihua, Rehnelt Jennifer, Petrosino Stefania, Starowicz Katarzyna, Steuder Regina, Schlicker Eberhard, Cravatt Benjamin, Mechoulam Raphael, Buettner Reinhard, Werner Sabine, Di Marzo Vincenzo, Tüting Thomas, Zimmer Andreas, ;2007;Science (New York, N.Y.);316;1494-7; 17556587
  • Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.;Járai Z, Wagner J A, Varga K, Lake K D, Compton D R, Martin B R, Zimmer A M, Bonner T I, Buckley N E, Mezey E, Razdan R K, Zimmer A, Kunos G, ;1999;Proceedings of the National Academy of Sciences of the United States of America;96;14136-41; 10570211

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany
Animals used for archivinghomozygous C57BL/6N

Disease and phenotype information

IMPC phenotypes (gene matching)
  • preweaning lethality, incomplete penetrance / IMPC
  • enlarged spleen / IMPC
  • enlarged cecum / IMPC
  • hyperactivity / IMPC
  • abnormal skin morphology / IMPC
  • decreased thigmotaxis / IMPC
  • edema / IMPC
  • abnormal behavior / IMPC
  • abnormal spleen morphology / IMPC
  • abnormal kidney morphology / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • small kidney / IMPC
  • abnormal cecum morphology / IMPC
  • increased bone mineral content / IMPC
  • abnormal skin morphology / IMPC
MGI phenotypes (allele matching)
  • hypoactivity / MGI
  • increased circulating corticosterone level / MGI
  • increased thermal nociceptive threshold / MGI
  • premature death / MGI
  • decreased vertical activity / MGI
  • catalepsy / MGI
  • hypoalgesia / MGI
  • maternal effect / MGI
  • increased follicle stimulating hormone level / MGI
  • increased circulating estradiol level / MGI
  • decreased circulating progesterone level / MGI
  • increased chemical nociceptive threshold / MGI
  • decreased survivor rate / MGI
  • impaired behavioral response to addictive substance / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • early parturition / MGI
  • abnormal macrophage physiology / MGI
  • immune system phenotype / MGI
  • reproductive system phenotype / MGI
MGI phenotypes (gene matching)
  • increased bone mineral density / MGI
  • abnormal cerebral cortex morphology / MGI
  • decreased body weight / MGI
  • weight loss / MGI
  • increased aggression towards mice / MGI
  • increased anxiety-related response / MGI
  • hyperactivity / MGI
  • hypoactivity / MGI
  • increased exploration in new environment / MGI
  • decreased exploration in new environment / MGI
  • abnormal cued conditioning behavior / MGI
  • reduced long term depression / MGI
  • increased circulating corticosterone level / MGI
  • increased circulating adrenocorticotropin level / MGI
  • absent long term depression / MGI
  • increased thermal nociceptive threshold / MGI
  • increased chemically-elicited antinociception / MGI
  • decreased chemically-elicited antinociception / MGI
  • abnormal learning/memory/conditioning / MGI
  • premature death / MGI
  • no abnormal phenotype detected / MGI
  • abnormal social/conspecific interaction / MGI
  • abnormal sperm motility / MGI
  • decreased circulating insulin level / MGI
  • decreased vertical activity / MGI
  • abnormal active avoidance behavior / MGI
  • catalepsy / MGI
  • increased insulin sensitivity / MGI
  • increased susceptibility to pharmacologically induced seizures / MGI
  • abnormal excitatory postsynaptic potential / MGI
  • decreased synaptic depression / MGI
  • abnormal paired-pulse facilitation / MGI
  • abnormal inhibitory postsynaptic currents / MGI
  • enhanced long term potentiation / MGI
  • no phenotypic analysis / MGI
  • hypoalgesia / MGI
  • increased susceptibility to ischemic brain injury / MGI
  • abnormal depression-related behavior / MGI
  • abnormal response to novel object / MGI
  • nervous system phenotype / MGI
  • abnormal nervous system morphology / MGI
  • abnormal nervous system physiology / MGI
  • maternal effect / MGI
  • abnormal nervous system development / MGI
  • abnormal sweet taste sensitivity / MGI
  • abnormal neuron physiology / MGI
  • abnormal synaptic plasticity / MGI
  • abnormal neuronal precursor proliferation / MGI
  • increased follicle stimulating hormone level / MGI
  • increased circulating estradiol level / MGI
  • decreased circulating progesterone level / MGI
  • behavior/neurological phenotype / MGI
  • skeleton phenotype / MGI
  • abnormal food intake / MGI
  • decreased percent body fat/body weight / MGI
  • decreased susceptibility to diet-induced obesity / MGI
  • decreased circulating leptin level / MGI
  • increased cerebral infarction size / MGI
  • increased susceptibility to neuronal excitotoxicity / MGI
  • increased chemical nociceptive threshold / MGI
  • decreased survivor rate / MGI
  • increased physiological sensitivity to xenobiotic / MGI
  • abnormal axon fasciculation / MGI
  • impaired cued conditioning behavior / MGI
  • anhedonia / MGI
  • impaired conditioned place preference behavior / MGI
  • impaired behavioral response to xenobiotic / MGI
  • impaired behavioral response to addictive substance / MGI
  • impaired behavioral response to morphine / MGI
  • increased sensitivity to induced morbidity/mortality / MGI
  • increased sensitivity to xenobiotic induced morbidity/mortality / MGI
  • increased behavioral withdrawal response / MGI
  • decreased total body fat amount / MGI
  • abnormal bone mineral density / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • early parturition / MGI
  • alopecia / MGI
  • abnormal macrophage physiology / MGI
  • immune system phenotype / MGI
  • reproductive system phenotype / MGI

Literature references

  • Attenuation of allergic contact dermatitis through the endocannabinoid system.;Karsak Meliha, Gaffal Evelyn, Date Rahul, Wang-Eckhardt Lihua, Rehnelt Jennifer, Petrosino Stefania, Starowicz Katarzyna, Steuder Regina, Schlicker Eberhard, Cravatt Benjamin, Mechoulam Raphael, Buettner Reinhard, Werner Sabine, Di Marzo Vincenzo, Tüting Thomas, Zimmer Andreas, ;2007;Science (New York, N.Y.);316;1494-7; 17556587
  • Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.;Járai Z, Wagner J A, Varga K, Lake K D, Compton D R, Martin B R, Zimmer A M, Bonner T I, Buckley N E, Mezey E, Razdan R K, Zimmer A, Kunos G, ;1999;Proceedings of the National Academy of Sciences of the United States of America;96;14136-41; 10570211

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).